| Steven A Rupert, DO | |
|
4645 Village Square Dr Ste C, Paducah, KY 42001-7448 | |
| (270) 228-0118 | |
| (270) 228-0120 |
| Full Name | Steven A Rupert |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation - Pain Medicine |
| Location | 4645 Village Square Dr Ste C, Paducah, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295732055 | NPI | - | NPPES |
| 200850420A | Medicaid | IN | |
| 100179690 | Medicaid | IN | |
| 64873391 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 02001097 (Indiana) | Primary |
| Entity Name | Shadeland Anesthesia & Pain Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477589000 PECOS PAC ID: 2769468990 Enrollment ID: O20040628000781 |
News Archive
For improving the health of babies by stopping early elective deliveries, Women's Services and Children's Hospital at the University of Virginia have earned a prestigious award from the March of Dimes and the Virginia Hospital & Healthcare Association (VHHA).
Zalicus Inc. announced today that preclinical data on its discovery of novel A2A agonist oncology programs for the treatment of multiple myeloma and other B-cell malignancies will be highlighted at the 52nd Annual Meeting of the American Society of Hematology in Orlando, FL on December 4-7, 2010.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Neogenix Oncology announced today that the company has filed a patent application with the U.S. Patent and Trade Office (USPTO) for the 16C3 antigen. The Company believes that this antigen is tumor specific for pancreatic and colorectal tumors; and, based on preliminary clinical data, may also have diagnostic utility as a biomarker for these cancers.
Young black patients and patients without private health insurance are less likely to be assessed for a kidney transplant when they start dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven A Rupert, DO 4645 Village Square Dr Ste C, Paducah, KY 42001-7448 Ph: (270) 228-0118 | Steven A Rupert, DO 4645 Village Square Dr Ste C, Paducah, KY 42001-7448 Ph: (270) 228-0118 |
News Archive
For improving the health of babies by stopping early elective deliveries, Women's Services and Children's Hospital at the University of Virginia have earned a prestigious award from the March of Dimes and the Virginia Hospital & Healthcare Association (VHHA).
Zalicus Inc. announced today that preclinical data on its discovery of novel A2A agonist oncology programs for the treatment of multiple myeloma and other B-cell malignancies will be highlighted at the 52nd Annual Meeting of the American Society of Hematology in Orlando, FL on December 4-7, 2010.
Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.
Neogenix Oncology announced today that the company has filed a patent application with the U.S. Patent and Trade Office (USPTO) for the 16C3 antigen. The Company believes that this antigen is tumor specific for pancreatic and colorectal tumors; and, based on preliminary clinical data, may also have diagnostic utility as a biomarker for these cancers.
Young black patients and patients without private health insurance are less likely to be assessed for a kidney transplant when they start dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 7 days ago
Monte E Rommelman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5150 Village Square Dr, Paducah, KY 42001 Phone: 270-443-9352 Fax: 270-443-9013 |